$TECH
BIO-TECHNE Corp

2024 Q4 Form 10-Q Financial Statement

#000155837024014439 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $289.5M
YoY Change 4.52%
Cost Of Revenue $106.4M
YoY Change 16.02%
Gross Profit $183.0M
YoY Change -1.17%
Gross Profit Margin 63.23%
Selling, General & Admin $119.2M
YoY Change 13.13%
% of Gross Profit 65.11%
Research & Development $23.87M
YoY Change -0.54%
% of Gross Profit 13.04%
Depreciation & Amortization $28.14M
YoY Change -1.41%
% of Gross Profit 15.37%
Operating Expenses $143.0M
YoY Change 10.59%
Operating Profit $39.99M
YoY Change -28.42%
Interest Expense -$876.0K
YoY Change -117.9%
% of Operating Profit -2.19%
Other Income/Expense, Net $184.0K
YoY Change -102.92%
Pretax Income $40.17M
YoY Change -18.94%
Income Tax $6.571M
% Of Pretax Income 16.36%
Net Earnings $33.60M
YoY Change -34.11%
Net Earnings / Revenue 11.61%
Basic Earnings Per Share $0.21
Diluted Earnings Per Share $0.21
COMMON SHARES
Basic Shares Outstanding 158.9M 158.6M
Diluted Shares Outstanding 161.1M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $187.5M
YoY Change 26.12%
Cash & Equivalents $187.5M
Short-Term Investments
Other Short-Term Assets $42.84M
YoY Change -17.88%
Inventory $185.0M
Prepaid Expenses
Receivables $223.7M
Other Receivables $0.00
Total Short-Term Assets $648.6M
YoY Change 9.65%
LONG-TERM ASSETS
Property, Plant & Equipment $253.9M
YoY Change 9.61%
Goodwill $982.6M
YoY Change 1.36%
Intangibles $486.0M
YoY Change -16.06%
Long-Term Investments $241.3M
YoY Change -4.11%
Other Assets $275.7M
YoY Change -2.09%
Total Long-Term Assets $2.087B
YoY Change -3.53%
TOTAL ASSETS
Total Short-Term Assets $648.6M
Total Long-Term Assets $2.087B
Total Assets $2.736B
YoY Change -0.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.56M
YoY Change 12.37%
Accrued Expenses $21.09M
YoY Change 32.32%
Deferred Revenue $26.61M
YoY Change 8.56%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $142.1M
YoY Change 11.25%
LONG-TERM LIABILITIES
Long-Term Debt $300.0M
YoY Change -31.82%
Other Long-Term Liabilities $19.79M
YoY Change 110.66%
Total Long-Term Liabilities $19.79M
YoY Change 110.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $142.1M
Total Long-Term Liabilities $19.79M
Total Liabilities $161.9M
YoY Change 18.06%
SHAREHOLDERS EQUITY
Retained Earnings $1.341B
YoY Change 1.02%
Common Stock $857.6M
YoY Change 14.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.139B
YoY Change
Total Liabilities & Shareholders Equity $2.736B
YoY Change -0.7%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $33.60M
YoY Change -34.11%
Depreciation, Depletion And Amortization $28.14M
YoY Change -1.41%
Cash From Operating Activities $63.89M
YoY Change 7.59%
INVESTING ACTIVITIES
Capital Expenditures $9.172M
YoY Change -32.52%
Acquisitions
YoY Change
Other Investing Activities -$12.51M
YoY Change -91.09%
Cash From Investing Activities -$21.68M
YoY Change -85.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.57M
YoY Change -116.18%
NET CHANGE
Cash From Operating Activities 63.89M
Cash From Investing Activities -21.68M
Cash From Financing Activities -11.57M
Net Change In Cash 35.75M
YoY Change -212.04%
FREE CASH FLOW
Cash From Operating Activities $63.89M
Capital Expenditures $9.172M
Free Cash Flow $54.72M
YoY Change 19.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000842023
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q2 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
BIO-TECHNE Corp
CY2024Q3 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3 dei Amendment Flag
AmendmentFlag
false
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
0-17272
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1427402
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
614 McKinley Place N.E.
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55413
CY2024Q3 dei City Area Code
CityAreaCode
612
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
379-8854
CY2024Q3 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2024Q3 dei Trading Symbol
TradingSymbol
TECH
CY2024Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
158891800
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
289458000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
276935000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
106441000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
91744000
CY2024Q3 us-gaap Gross Profit
GrossProfit
183017000
CY2023Q3 us-gaap Gross Profit
GrossProfit
185191000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
119161000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105331000
CY2024Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
23869000
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
23998000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
143030000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
129329000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
39987000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
55862000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
184000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6304000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
40171000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49558000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6571000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1435000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
33600000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
50993000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
21256000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-11602000
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-3027000
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-350000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
18229000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11952000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
51829000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39041000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158531000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158130000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161115000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161940000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187540000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151791000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
1072000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4904000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4386000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
223688000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
241394000
CY2024Q3 us-gaap Inventory Net
InventoryNet
185041000
CY2024Q2 us-gaap Inventory Net
InventoryNet
179731000
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
9459000
CY2024Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
9773000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
42839000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
33658000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
648567000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
617419000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
253939000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
251154000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
89221000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
91285000
CY2024Q3 us-gaap Goodwill
Goodwill
982585000
CY2024Q2 us-gaap Goodwill
Goodwill
972663000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
486004000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
507081000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
275701000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
264265000
CY2024Q3 us-gaap Assets
Assets
2736017000
CY2024Q2 us-gaap Assets
Assets
2703867000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
31559000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
37968000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
41977000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
49818000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21088000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24886000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
26614000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
27930000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3136000
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3706000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13485000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12920000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4269000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2151000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
142128000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
159379000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
50017000
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
55863000
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
300000000
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
319000000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
85433000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87618000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19789000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13157000
CY2024Q3 tech Undesignated Capital Stock No Par Value
UndesignatedCapitalStockNoParValue
0
CY2024Q2 tech Undesignated Capital Stock No Par Value
UndesignatedCapitalStockNoParValue
0
CY2024Q3 tech Undesignated Capital Stock Shares Authorized
UndesignatedCapitalStockSharesAuthorized
5000000
CY2024Q2 tech Undesignated Capital Stock Shares Authorized
UndesignatedCapitalStockSharesAuthorized
5000000
CY2024Q3 tech Undesignated Capital Stock Shares Outstanding
UndesignatedCapitalStockSharesOutstanding
0
CY2024Q2 tech Undesignated Capital Stock Shares Outstanding
UndesignatedCapitalStockSharesOutstanding
0
CY2024Q3 tech Undesignated Capital Stock Shares Issued
UndesignatedCapitalStockSharesIssued
0
CY2024Q2 tech Undesignated Capital Stock Shares Issued
UndesignatedCapitalStockSharesIssued
0
CY2024Q3 tech Undesignated Capital Stock Value
UndesignatedCapitalStockValue
0
CY2024Q2 tech Undesignated Capital Stock Value
UndesignatedCapitalStockValue
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
158878127
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
158878127
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
158216258
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
158216258
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1589000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1582000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
855973000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
820337000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1341175000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1325247000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-60087000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-78316000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2138650000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2068850000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2736017000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2703867000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
33600000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
50993000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28137000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28540000
CY2024Q3 tech Fair Value Write Up Of Acquired Inventory
FairValueWriteUpOfAcquiredInventory
188000
CY2023Q3 tech Fair Value Write Up Of Acquired Inventory
FairValueWriteUpOfAcquiredInventory
181000
CY2024Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5340000
CY2023Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-11591000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
10184000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
10093000
CY2023Q3 tech Fair Value Adjustment To Contingent Consideration Payable
FairValueAdjustmentToContingentConsiderationPayable
-1750000
CY2023Q3 tech Fair Value Adjustment On Available For Sale Securities
FairValueAdjustmentOnAvailableForSaleSecurities
-283000
CY2024Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
374000
CY2023Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-2382000
CY2024Q3 tech Asset Impairment Restructuring Charge
AssetImpairmentRestructuringCharge
6039000
CY2024Q3 tech Noncash Portion Of Lease Expense
NoncashPortionOfLeaseExpense
445000
CY2023Q3 tech Noncash Portion Of Lease Expense
NoncashPortionOfLeaseExpense
613000
CY2024Q3 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
747000
CY2023Q3 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
182000
CY2024Q3 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-21563000
CY2023Q3 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-15599000
CY2024Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2805000
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5216000
CY2024Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3158000
CY2023Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2572000
CY2024Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10911000
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2695000
CY2024Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8246000
CY2023Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2157000
CY2024Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-6180000
CY2023Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-22936000
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63889000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
59383000
CY2024Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1085000
CY2023Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
23759000
CY2024Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9172000
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13592000
CY2023Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
166426000
CY2024Q3 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1403000
CY2023Q3 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2149000
CY2024Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
15000000
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21684000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-154110000
CY2024Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12688000
CY2023Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12654000
CY2024Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25101000
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14394000
CY2023Q3 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
160000000
CY2024Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
19000000
CY2023Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
70000000
CY2024Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4984000
CY2023Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
20228000
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11571000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71512000
CY2024Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5115000
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-8693000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
35749000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31908000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
151791000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
180571000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
187540000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
148663000
CY2024Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
16490000
CY2023Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
32797000
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
5205000
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
4506000
CY2024Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
804162
CY2024Q3 tech Share Based Compensation Arrangement By Share Based Payment Award Options Expired Options In Period Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOptionsInPeriodValue
33000000
CY2024Q3 us-gaap Legal Fees
LegalFees
300000
CY2023Q3 us-gaap Legal Fees
LegalFees
0
CY2024Q3 us-gaap Litigation Reserve
LitigationReserve
0
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
29200000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
30200000
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
11800000
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
11800000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
289458000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
276935000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
289458000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
276935000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
81786000
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
79377000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
108811000
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
106072000
CY2024Q3 tech Inventory Net Current And Non Current
InventoryNetCurrentAndNonCurrent
190597000
CY2024Q2 tech Inventory Net Current And Non Current
InventoryNetCurrentAndNonCurrent
185449000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
519201000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
507710000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
265262000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
256556000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
253939000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
251154000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1056827000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1054860000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
570823000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
547779000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
486004000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
507081000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
507081000
CY2024Q3 tech Finitelived Intangible Assets Other Additions
FinitelivedIntangibleAssetsOtherAdditions
112000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20040000
CY2024Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
5474000
CY2024Q3 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
-4325000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
486004000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
59111000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
72743000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
62540000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
58821000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
46200000
CY2024Q3 tech Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
186589000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
486004000
CY2024Q2 us-gaap Goodwill
Goodwill
972663000
CY2024Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
9922000
CY2024Q3 us-gaap Goodwill
Goodwill
982585000
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
241308000
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
242337000
CY2024Q3 us-gaap Derivative Assets
DerivativeAssets
6669000
CY2024Q2 us-gaap Derivative Assets
DerivativeAssets
9813000
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
5556000
CY2024Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
5718000
CY2024Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
15000000
CY2024Q3 tech Assets Classified As Noncurrent Other
AssetsClassifiedAsNoncurrentOther
7168000
CY2024Q2 tech Assets Classified As Noncurrent Other
AssetsClassifiedAsNoncurrentOther
6397000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
275701000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
264265000
CY2024Q3 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
-3381000
CY2023Q3 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
-3237000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1300000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
4400000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
89221000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13485000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
85433000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
98918000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M18D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0424
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
3885000
CY2024Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
799000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
12668000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
16647000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
13767000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
13593000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13125000
CY2024Q3 tech Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
48790000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
118590000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19672000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
98918000
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2068850000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
33600000
CY2024Q3 tech Other Comprehensive Income Loss Before Translation Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeTranslationReclassificationNetOfTax
18229000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20892000
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2644000
CY2024Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12688000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10146000
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2227000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
38000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2138650000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1966516000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
50993000
CY2023Q3 tech Other Comprehensive Income Loss Before Translation Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeTranslationReclassificationNetOfTax
-11952000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-2577000
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4767000
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12654000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9981000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2094000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
112000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1997746000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
33600000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
50993000
CY2024Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
6000
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
8000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
33594000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
50985000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158531000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158130000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
33600000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
50993000
CY2024Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
6000
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
8000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
33594000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
50985000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158531000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158130000
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2584000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3810000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161115000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161940000
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4100000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4100000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
800000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
800000
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
74.85
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
74.85
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
84.34
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.32
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.32
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
28.58
CY2024Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
648293
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1027777
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
23500000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
54300000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
72500000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2176000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
4893000
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
926000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
890000
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
283000
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
374000
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2290000
CY2024Q3 tech Other Nonoperating Income And Expense
OtherNonoperatingIncomeAndExpense
1060000
CY2023Q3 tech Other Nonoperating Income And Expense
OtherNonoperatingIncomeAndExpense
-294000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
184000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6304000
CY2023Q3 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
300000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.164
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.029
CY2024Q3 tech Income Tax Expense Benefit Discrete Tax Items
IncomeTaxExpenseBenefitDiscreteTaxItems
3000000.0
CY2023Q3 tech Income Tax Expense Benefit Discrete Tax Items
IncomeTaxExpenseBenefitDiscreteTaxItems
-13600000
CY2024Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3300000
CY2023Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
10400000
CY2024Q3 tech Income Tax Expense Benefit Other Immaterial Discrete Tax Items Net
IncomeTaxExpenseBenefitOtherImmaterialDiscreteTaxItemsNet
300000
CY2023Q3 tech Income Tax Expense Benefit Other Immaterial Discrete Tax Items Net
IncomeTaxExpenseBenefitOtherImmaterialDiscreteTaxItemsNet
-3200000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
289458000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
276935000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
39987000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
55862000

Files In Submission

Name View Source Status
0001558370-24-014439-index-headers.html Edgar Link pending
0001558370-24-014439-index.html Edgar Link pending
0001558370-24-014439.txt Edgar Link pending
0001558370-24-014439-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tech-20240930.xsd Edgar Link pending
tech-20240930x10q.htm Edgar Link pending
tech-20240930xex31d1.htm Edgar Link pending
tech-20240930xex31d2.htm Edgar Link pending
tech-20240930xex32d1.htm Edgar Link pending
tech-20240930xex32d2.htm Edgar Link pending
tech-20240930_def.xml Edgar Link unprocessable
tech-20240930_lab.xml Edgar Link unprocessable
tech-20240930_pre.xml Edgar Link unprocessable
tech-20240930x10q_htm.xml Edgar Link completed
tech-20240930_cal.xml Edgar Link unprocessable